GB2453819A - Modulators of hypoxia inducible factor-1 and related uses - Google Patents
Modulators of hypoxia inducible factor-1 and related uses Download PDFInfo
- Publication number
- GB2453819A GB2453819A GB0812342A GB0812342A GB2453819A GB 2453819 A GB2453819 A GB 2453819A GB 0812342 A GB0812342 A GB 0812342A GB 0812342 A GB0812342 A GB 0812342A GB 2453819 A GB2453819 A GB 2453819A
- Authority
- GB
- United Kingdom
- Prior art keywords
- modulators
- inducible factor
- hypoxia inducible
- related uses
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J19/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 by a lactone ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J19/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 by a lactone ring
- C07J19/005—Glycosides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
- C07J41/0011—Unsubstituted amino radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
- C07J41/0016—Oximes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
- C07J41/0027—Azides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0038—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 with an androstane skeleton, including 18- or 19-substituted derivatives, 18-nor derivatives and also derivatives where position 17-beta is substituted by a carbon atom not directly bonded to a further carbon atom and not being part of an amide group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0088—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing unsubstituted amino radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
Abstract
The invention features compounds of formulas I or II: and pharmaceutically acceptable salts and prodrugs thereof, as well methods for modulating the effects of local and systemic hypoxic events using the compounds.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US75781406P | 2006-01-09 | 2006-01-09 | |
PCT/US2007/000340 WO2007081835A2 (en) | 2006-01-09 | 2007-01-09 | Modulators of hypoxia inducible factor-1 and related uses |
Publications (2)
Publication Number | Publication Date |
---|---|
GB0812342D0 GB0812342D0 (en) | 2008-08-13 |
GB2453819A true GB2453819A (en) | 2009-04-22 |
Family
ID=38256942
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0812342A Withdrawn GB2453819A (en) | 2006-01-09 | 2007-01-09 | Modulators of hypoxia inducible factor-1 and related uses |
Country Status (10)
Country | Link |
---|---|
US (1) | US20090023666A1 (en) |
EP (1) | EP1971618A2 (en) |
JP (1) | JP2009522383A (en) |
CN (1) | CN101400690A (en) |
AU (1) | AU2007205092A1 (en) |
BR (1) | BRPI0706377A2 (en) |
CA (1) | CA2635370A1 (en) |
GB (1) | GB2453819A (en) |
MX (1) | MX2008008608A (en) |
WO (1) | WO2007081835A2 (en) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0713463D0 (en) * | 2007-07-11 | 2007-08-22 | Btg Int Ltd | Modulators of hypoxia inducible factor-1 and related uses |
JP2011530535A (en) | 2008-08-07 | 2011-12-22 | セントローズ, エルエルシー | Glycoside compound and pharmaceutical composition thereof |
WO2010024930A2 (en) * | 2008-08-28 | 2010-03-04 | President And Fellows Of Harvard College | Cortistatin analogues and syntheses therof |
WO2010102673A1 (en) * | 2009-03-13 | 2010-09-16 | Unibioscreen S.A. | Hellebrin and hellebrigenin derivatives |
JP2012524778A (en) * | 2009-04-22 | 2012-10-18 | プレジデント アンド フェロウズ オブ ハーバード カレッジ | Angiogenesis inhibitor |
CN103980338B (en) | 2010-01-15 | 2017-04-26 | 苏州润新生物科技有限公司 | Bufalin derivatives, pharmaceutical compositions and methods thereof |
WO2012027957A1 (en) | 2010-08-28 | 2012-03-08 | Suzhou Neupharma Co., Ltd. | Bufalin derivatives, pharmaceutical compositions and use thereof |
EP3453714B1 (en) | 2011-02-02 | 2020-11-04 | Suzhou Neupharma Co., Ltd | Cardenolide and bufadienolide 3-carbonate and 3-carbamate derivatives for the treatment of cancer and compositions thereof |
NO2686520T3 (en) | 2011-06-06 | 2018-03-17 | ||
KR101380466B1 (en) * | 2011-09-27 | 2014-04-02 | 한국생명공학연구원 | Novel compounds as HIF-1α inhibitors and manufacturing process thereof |
CN109354598A (en) * | 2012-04-29 | 2019-02-19 | 润新生物公司 | Chemical entity, pharmaceutical composition and cancer treatment method |
CN103570792B (en) * | 2012-08-10 | 2016-09-14 | 中国科学院上海药物研究所 | Toadpoison Medicine derivant, its preparation method, pharmaceutical composition and purposes |
PT3007695T (en) | 2013-06-13 | 2024-03-07 | Akebia Therapeutics Inc | Compositions and methods for treating anemia |
PE20160945A1 (en) | 2013-11-15 | 2016-09-26 | Akebia Therapeutics Inc | SOLID FORMS OF {[5- (3-CHLOROPHENYL) -3-HYDROXYPYRIDIN-2-CARBONYL] AMINO} ACID, COMPOSITIONS, AND USES OF THEM |
EA201891279A1 (en) | 2013-12-24 | 2019-01-31 | Президент Энд Феллоус Оф Гарвард Колледж | ANALOGUES OF CORTISTATIN, THEIR SYNTHESIS AND APPLICATIONS |
CA2974691A1 (en) | 2015-01-23 | 2016-07-28 | Akebia Therapeutics, Inc. | Solid forms of 2-(5-(3-fluorophenyl)-3-hydroxypicolinamido)acetic acid, compositions, and uses thereof |
IL292262B2 (en) | 2015-04-01 | 2024-02-01 | Akebia Therapeutics Inc | Oral dosage formulation of {[ 5-(3-(chlorophenyl)- 3-hydroxypyridine-2-carbonyl] amino} acetic acid |
EP3294298A4 (en) | 2015-05-08 | 2018-10-17 | President and Fellows of Harvard College | Cortistatin analogues, syntheses, and uses thereof |
EP3316889A4 (en) | 2015-07-01 | 2018-11-14 | President and Fellows of Harvard College | Cortistatin analogues and syntheses and uses thereof |
AU2019265629A1 (en) | 2018-05-09 | 2021-01-07 | Akebia Therapeutics, Inc. | Process for preparing 2-((5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl)amino)acetic acid |
US11524939B2 (en) | 2019-11-13 | 2022-12-13 | Akebia Therapeutics, Inc. | Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino} acetic acid |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1346350A (en) * | 1970-07-24 | 1974-02-06 | Hoffmann La Roche | Cardenolides and bufadienolides and a process for the manu facture thereof |
US3914213A (en) * | 1972-11-04 | 1975-10-21 | Hoechst Ag | Cardenolido-3-{8 4{40 -amino-2{40 , 3{40 , 4{40 -tridesoxy-glycosides{9 {0 and process for their manufacture |
DD142889A1 (en) * | 1979-04-05 | 1980-07-16 | Konrad Schwabe | PROCESS FOR PREPARING ALPHA-L-ARABINOFURANOSIDES HERZWIRKSAMER CARDENOLIDSTEROIDE |
WO2002014343A1 (en) * | 2000-08-17 | 2002-02-21 | Terness, Peter | Bufadienolide derivatives and use as immunosuppressive, antiinflammatory and analgesic agents |
WO2005060951A2 (en) * | 2003-12-19 | 2005-07-07 | Bionaut Pharmaceuticals, Inc. | Anti-neoplastic agents, combination therapies and related methods |
WO2006002381A1 (en) * | 2004-06-24 | 2006-01-05 | Wisconsin Alumni Research Foundation | Neoglycorandomization and digitoxin analogs |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2013032C3 (en) * | 1970-03-19 | 1978-12-07 | Hoechst Ag, 6000 Frankfurt | 3-Amino-cardenolide, process for their preparation and their use in combating cardiovascular diseases |
US3901882A (en) * | 1970-07-24 | 1975-08-26 | Hoffmann La Roche | 3-amino cardenolides and bufadienolides, derivatives and salts thereof |
US20060009506A1 (en) * | 2004-07-09 | 2006-01-12 | Odyssey Thera, Inc. | Drugs for the treatment of neoplastic disorders |
WO2006029018A2 (en) * | 2004-09-02 | 2006-03-16 | Bionaut Pharmaceuticals, Inc. | Combinatorial chemotherapy treatment using na+/k+-atpase inhibitors |
WO2006028969A1 (en) * | 2004-09-02 | 2006-03-16 | Bionaut Pharmaceuticals, Inc. | Pancreatic cancer treatment using na+/k+ atpase inhibitors |
US20060135468A1 (en) * | 2004-09-02 | 2006-06-22 | Bionaut Pharmaceuticals, Inc. | Treatment of refractory cancers using NA+/K+ ATPase inhibitors |
US20080027010A1 (en) * | 2004-09-02 | 2008-01-31 | Bionaut Pharmaceuticals, Inc. | Treatment of refractory cancers using Na+/K+-ATPase inhibitors |
EP1812010A2 (en) * | 2004-10-18 | 2007-08-01 | BTG International Limited | Use of na+/ k+-atpase inhibitors and antagonists thereof |
US20110076278A1 (en) * | 2005-08-02 | 2011-03-31 | Mehran Khodadoust | Modulators of Hypoxia Inducible Factor-1 and Related Uses for the Treatment of Ocular Disorders |
GB0713463D0 (en) * | 2007-07-11 | 2007-08-22 | Btg Int Ltd | Modulators of hypoxia inducible factor-1 and related uses |
-
2007
- 2007-01-09 MX MX2008008608A patent/MX2008008608A/en not_active Application Discontinuation
- 2007-01-09 GB GB0812342A patent/GB2453819A/en not_active Withdrawn
- 2007-01-09 US US12/087,459 patent/US20090023666A1/en not_active Abandoned
- 2007-01-09 CA CA002635370A patent/CA2635370A1/en not_active Abandoned
- 2007-01-09 JP JP2008550353A patent/JP2009522383A/en active Pending
- 2007-01-09 EP EP07717832A patent/EP1971618A2/en not_active Withdrawn
- 2007-01-09 WO PCT/US2007/000340 patent/WO2007081835A2/en active Application Filing
- 2007-01-09 BR BRPI0706377-6A patent/BRPI0706377A2/en not_active Application Discontinuation
- 2007-01-09 CN CNA2007800085277A patent/CN101400690A/en active Pending
- 2007-01-09 AU AU2007205092A patent/AU2007205092A1/en not_active Abandoned
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1346350A (en) * | 1970-07-24 | 1974-02-06 | Hoffmann La Roche | Cardenolides and bufadienolides and a process for the manu facture thereof |
US3914213A (en) * | 1972-11-04 | 1975-10-21 | Hoechst Ag | Cardenolido-3-{8 4{40 -amino-2{40 , 3{40 , 4{40 -tridesoxy-glycosides{9 {0 and process for their manufacture |
DD142889A1 (en) * | 1979-04-05 | 1980-07-16 | Konrad Schwabe | PROCESS FOR PREPARING ALPHA-L-ARABINOFURANOSIDES HERZWIRKSAMER CARDENOLIDSTEROIDE |
WO2002014343A1 (en) * | 2000-08-17 | 2002-02-21 | Terness, Peter | Bufadienolide derivatives and use as immunosuppressive, antiinflammatory and analgesic agents |
WO2005060951A2 (en) * | 2003-12-19 | 2005-07-07 | Bionaut Pharmaceuticals, Inc. | Anti-neoplastic agents, combination therapies and related methods |
WO2006002381A1 (en) * | 2004-06-24 | 2006-01-05 | Wisconsin Alumni Research Foundation | Neoglycorandomization and digitoxin analogs |
Non-Patent Citations (9)
Title |
---|
Arch. Pharm., 1985, Vol.318, Roeder et al., pp.837-842. * |
Chem. Pharm. Bull., 1970, Vol.18(3), Saito et al., pp.629-631. * |
Chem. Pharm. Bull., 1973, Vol.21(5), Shimada et al., pp.1031-1036. * |
Chemistry of Natural Compounds, 2005, Vol.41(1), Makarevich et al., pp.52-55. * |
Experientia, 1980, Vol.36(10), Monji et al., pp.1141-1143. * |
Farmaco, Edizione Scientifica, 1981, Vol.36(11), Valcavi et al., pp.971-982. * |
Helvetica Chimica Acta, 1955, Vol.38(6), Pataki et al., pp.1631-1649. * |
Internal Immunopharmacology, 2001, Vol.1, Terness et al., pp.119-134. * |
Pharmazie, 1995, Vol.50(10), Heber et al., pp.663-667. * |
Also Published As
Publication number | Publication date |
---|---|
JP2009522383A (en) | 2009-06-11 |
WO2007081835A3 (en) | 2008-08-14 |
EP1971618A2 (en) | 2008-09-24 |
US20090023666A1 (en) | 2009-01-22 |
CA2635370A1 (en) | 2007-07-09 |
MX2008008608A (en) | 2009-03-04 |
GB0812342D0 (en) | 2008-08-13 |
CN101400690A (en) | 2009-04-01 |
WO2007081835A2 (en) | 2007-07-19 |
AU2007205092A1 (en) | 2007-07-19 |
BRPI0706377A2 (en) | 2011-03-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2453819A (en) | Modulators of hypoxia inducible factor-1 and related uses | |
MY153975A (en) | Pyridine derivatives as s1p1/edg1 receptor modulators | |
TW200745045A (en) | Imidazole based LXR modulators | |
MX2009009290A (en) | Ppar active compounds. | |
TW200744588A (en) | Pharmaceutical composition for external use | |
WO2007117465A3 (en) | Indazole compounds | |
MX340064B (en) | Azaadamantane derivatives and methods of use. | |
RS52780B (en) | Compound for preventing and treating disorders involving modulation of the ryr receptors | |
MX2012003539A (en) | Indole derivatives as crac modulators. | |
GEP201606555B (en) | Compounds and compositions for modulating egfr activity | |
UA94833C2 (en) | Substituted bicyclolactams | |
TW200800956A (en) | 2-Aminopyrimidine derivatives | |
WO2009042114A3 (en) | Phenazine derivatives and uses thereof | |
AU2009331669A8 (en) | Dihydropyridone amides as P2X7 modulators | |
UA103625C2 (en) | 5-hetrocyclylalkyl-3-hydroxy-2-phenylcyclopent-2-enons as herbicides | |
WO2007084728A3 (en) | 2-imino-benzimidazoles | |
MX2008013196A (en) | 5-amido-2-carboxamide indoles. | |
TW200942524A (en) | Novel aminomethyl benzene derivatives | |
GB2466912A (en) | Compositions and methods for treating lysosomal disorders | |
MY147188A (en) | Substituted imidazole compounds as ksp inhibitors | |
SG162803A1 (en) | Imidazole based lxr modulators | |
MX2009005071A (en) | Substituted pyrazole and triazole compounds as ksp inhibitors. | |
MX2009004358A (en) | Transdermal delivery of ketoprofen polar derivatives. | |
MX2009007336A (en) | 5-furopyridinone substituted indazoles. | |
MA32834B1 (en) | Aminocyclopentaneicarboxamide 3 acts as a shimokin receptor modulator |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |